Foghorn Therapeutics FHTX
NASDAQ FHTX
$2.08 +0.07 (+3.23%)
As of: Oct 21, 2026 · 1:50 PM EDT

Foghorn Therapeutics (FHTX) Short term Debt (2019 - 2020)

Updated

Foghorn Therapeutics (FHTX) recorded Short term Debt of $5.99 million in Q3 2020.

Analysis

Foghorn Therapeutics (FHTX) Short term Debt (2019 - 2020) Analysis & Trends

At the end of FY2019, Foghorn Therapeutics reported Short term Debt of $4.15 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,134.24 Bn 1,102.83 Bn 19.71 Bn
2 Johnson & Johnson 616.05 Bn 534.58 Bn 17.26 Bn
3 AbbVie 500.90 Bn 474.01 Bn 12.70 Bn
4 Merck 367.17 Bn 321.54 Bn 12.21 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn
6 Astrazeneca 261.35 Bn 235.03 Bn 12.86 Bn
7 Amgen 235.77 Bn 191.17 Bn 7.24 Bn
8 Gilead Sciences 190.70 Bn 164.90 Bn 6.22 Bn
9 Pfizer 169.35 Bn 115.99 Bn 10.94 Bn
10 Foghorn Therapeutics 146.56 Mn -179.40 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 5.99 Mn
Dec 31, 2019 4.15 Mn
API Access

Foghorn Therapeutics Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=FHTX&period=max&api_key=YOUR_API_KEY